Vycor Medical (VYCO) Income Statement
Vycor Medical Income Statement
Last quarter (Q2 2026), Vycor Medical's total revenue was $418.26K, a decrease of 15.73% from the same quarter last year. In Q2, Vycor Medical's net income was $-22.29K. See Vycor Medical’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.86M | $ 1.59M | $ 1.46M | $ 1.22M | $ 1.39M | |
| $ 1.50M | $ 1.42M | $ 1.32M | $ 1.08M | $ 1.26M | |
| $ 1.47M | $ 1.43M | $ 1.28M | $ 1.39M | $ 1.69M | |
| Depreciation and Amortization | $ 63.14K | $ 63.91K | $ 60.75K | $ 61.40K | $ 68.42K |
| $ 96.53K | $ 60.53K | $ 100.73K | $ -246.07K | $ -252.02K | |
| $ 33.90K | $ -9.14K | $ 40.19K | $ -306.51K | $ -435.95K | |
| $ -104.09K | $ -97.81K | $ -103.27K | $ -93.19K | $ 27.70K | |
| $ -70.19K | $ -106.95K | $ -63.08K | $ -399.70K | $ -408.25K | |
| $ -72.43K | $ -107.20K | $ -69.69K | $ -405.88K | $ -523.47K | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ 0.00 | $ -0.01 | $ -0.01 | $ -0.02 |
| Diluted EPS | $ -0.01 | $ 0.00 | $ -0.01 | $ -0.01 | $ -0.02 |
| Weighted Average Shares Outstanding | 33.37M | 32.88M | 32.60M | 31.71M | 29.63M |
| Weighted Average Shares Outstanding (Diluted) | 33.37M | 32.88M | 32.60M | 31.71M | 29.63M |
Currency in USD
